Ticagrelor

Mfr.No.	T0179
Description	Ticagrelor (AR-C 126532XX), produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique(EU) and Possia(EU).
Alternative Names	AZD6140
Molecular Formula	C23H28F2N6O4S
Signaling Pathways	GPCR/G Protein, Neuroscience, Metabolism
Smiles	N(C1=C2C(N(N=N2)(CH)3C(CH)(OCCO)(CH)(O)(CH)3O)=NC(SCCC)=N1)(CH)4(CH)(C4)C5=CC(F)=C(F)C=C5
Cas Number	274693-27-5
Molecular Weight	522.57
Target	P450, P2Y Receptor

Have you used this product?

SKU	Supplier No.	Size	Your price
BHB20400156	T0179	1 g	$383	Add to Cart
BHB20400156	T0179	1 mL	$54	Add to Cart
BHB20400156	T0179	10 mg	$40	Add to Cart
BHB20400156	T0179	25 mg	$60	Add to Cart
BHB20400156	T0179	50 mg	$74	Add to Cart
BHB20400156	T0179	100 mg	$111	Add to Cart
BHB20400156	T0179	200 mg	$156	Add to Cart
BHB20400156	T0179	500 mg	$258	Add to Cart